𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Placebo effect and randomized clinical trials

✍ Scribed by Gunnel Elander; Göran Hermerén

Publisher
Springer Netherlands
Year
1995
Tongue
English
Weight
723 KB
Volume
16
Category
Article
ISSN
1573-1200

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The placebo is powerful: Estimating plac
The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials
✍ Bruce E. Wampold; Takuya Minami; Sandra Callen Tierney; Thomas W. Baskin; Kuldhi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

The logic of the randomized double-blind placebo control group design is presented, and problems with using the design in psychotherapy are discussed. Placebo effects are estimated by examining clinical trials in medicine and psychotherapy. In medicine, a recent meta-analysis of clinical trials with

Does elimination of placebo responders i
Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation
✍ Sandra Lee; John R. Walker; Laura Jakul; Kathryn Sexton 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

The use of a placebo run-in phase, in which placebo responders are withdrawn from a study before random assignment to treatment condition, has been criticized as favoring the active treatment in clinical trials. We compared the effect size of randomized, placebo-controlled clinical trials (in the tr

Placebo and nocebo effects in randomized
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer
✍ Maxine de la Cruz; David Hui; Henrique A. Parsons; Eduardo Bruera 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract ## BACKGROUND: A significant response to placebo in randomized controlled trials of treatments for cancer‐related fatigue (CRF) had been reported. A retrospective study was conducted to determine the frequency and predictors of response to placebo effect and nocebo effects in patients